Cellectis CLLS
NASDAQ CLLS
$1.51 +0.04 (+2.72%)
At close: Sep 30, 2026 · 4:00 PM EDT

Cellectis (CLLS) Short term Debt (2015 - 2024)

Updated

Cellectis (CLLS) posted Short term Debt of $98.26 million for Q3 2024, up 1.6% from the prior quarter.

Analysis

Cellectis (CLLS) Short term Debt (2015 - 2024) Analysis & Trends

At the end of FY2023, Cellectis' Short term Debt came in at $10.1 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Cellectis 147.50 Mn -605.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 98.26 Mn
Jun 30, 2024 96.71 Mn
Dec 31, 2023 10.10 Mn
Dec 31, 2016 6.57 Mn
Dec 31, 2015 5.40 Mn
API Access

Cellectis Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=CLLS&period=max&api_key=YOUR_API_KEY